R Squared’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$73.4K Sell
16,998
-54
-0.3% -$236 0.04% 426
2026
Q1
$65.5K Buy
+17,052
New +$69.9K 0.04% 401
2025
Q4
Sell
-10,308
Closed -$146K 661
2025
Q3
$146K Buy
+10,308
New +$161K 0.06% 414
2025
Q1
Sell
-660
Closed -$11K 1113
2024
Q4
$11K Buy
+660
New +$8.24K 0.01% 1117

Other funds holding OM

R Squared's OM Position: Q2 2026 in Review

R Squared reduced its Outset Medical (OM) stake by 0.32% in Q2 2026, selling an estimated $236 and leaving 16,998 shares worth $73.4K. The position accounts for 0.04% of the portfolio, ranked #426.

R Squared first reported a position in OM in Q4 2024 and has held it in 4 quarters since. The position peaked at $146K in Q3 2025. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • R Squared held 16,998 shares of Outset Medical worth $73.4K as of Q2 2026.
  • R Squared sold 54 Outset Medical shares in Q2 2026, an estimated $236.
  • Outset Medical made up 0.04% of R Squared's portfolio in Q2 2026, its #426 holding.
  • R Squared first reported a position in Outset Medical in Q4 2024 and has held it in 4 quarters since.
  • R Squared's Outset Medical position peaked at $146K in Q3 2025.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.